Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer
Clinical trial NCT03759496 · UNKNOWN
Trial details
- NCT number
- NCT03759496
- Sponsor
- Hellenic GenitoUrinary Cancer Group
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2022-05-31
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.